Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goff

Showing results (31-40 of 625) with videos related to

Pageof 63
Sort By:
Schizophrenia Research|May 12, 2005
Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication statusDost Ongür, Donald C Goff
Behavioural Neurology|February 4, 2014
Possession states: approaches to clinical evaluation and classificationS McCormick, D C Goff
Harvard Review of Psychiatry|July 11, 2024
Why Do Veterans Not Respond as Well as Civilians to Trauma-Focused Therapies for PTSD?Max Kitaj, Donald C Goff
Biological Psychiatry|June 28, 2023
Dose Finding for d-Serine Enhancement of Plasticity in SchizophreniaKatlyn Nemani, Donald C Goff
The Journal of Clinical Psychiatry|November 25, 2003
Polypharmacy in schizophrenia: a fuzzy conceptOliver Freudenreich, Donald C Goff
The International Journal of Neuropsychopharmacology|May 13, 2004
Focus on polypharmacy in schizophrenia: does anyone truly benefit?Donald C Goff, Oliver Freudenreich
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1991
Apparent decrease in schizophreniaS McCormick, D C Goff
The American Journal of Psychiatry|July 5, 2011
Antipsychotic polypharmacy: are two ever better than one?Donald C Goff, Lisa Dixon
Annals of the New York Academy of Sciences|September 22, 2012
Population shifts and the future of stroke: forecasts of the future burden of strokeGeorge Howard, David C Goff
Schizophrenia Research|January 7, 1998
Glutamate in schizophrenia: clinical and research implicationsD C Goff, L Wine
Pageof 63

Showing results (31-40 of 625) with videos related to

Sort By:
Pageof 63
Schizophrenia Research|May 12, 2005
Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication statusDost Ongür, Donald C Goff
Behavioural Neurology|February 4, 2014
Possession states: approaches to clinical evaluation and classificationS McCormick, D C Goff
Harvard Review of Psychiatry|July 11, 2024
Why Do Veterans Not Respond as Well as Civilians to Trauma-Focused Therapies for PTSD?Max Kitaj, Donald C Goff
Biological Psychiatry|June 28, 2023
Dose Finding for d-Serine Enhancement of Plasticity in SchizophreniaKatlyn Nemani, Donald C Goff
The Journal of Clinical Psychiatry|November 25, 2003
Polypharmacy in schizophrenia: a fuzzy conceptOliver Freudenreich, Donald C Goff
The International Journal of Neuropsychopharmacology|May 13, 2004
Focus on polypharmacy in schizophrenia: does anyone truly benefit?Donald C Goff, Oliver Freudenreich
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1991
Apparent decrease in schizophreniaS McCormick, D C Goff
The American Journal of Psychiatry|July 5, 2011
Antipsychotic polypharmacy: are two ever better than one?Donald C Goff, Lisa Dixon
Annals of the New York Academy of Sciences|September 22, 2012
Population shifts and the future of stroke: forecasts of the future burden of strokeGeorge Howard, David C Goff
Schizophrenia Research|January 7, 1998
Glutamate in schizophrenia: clinical and research implicationsD C Goff, L Wine
Pageof 63